Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ESR1 | P03372 | 1/20 | 0.34 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.33 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | KCNN4 | O15554 | 1/20 | 0.33 |
| ▸ | CKS1B | P61024 | 1/20 | 0.32 |
| ▸ | SKP1 | P63208 | 1/20 | 0.32 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HRH1 | P35367 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.31 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.31 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.31 |
| ▸ | OPRL1 | P41146 | 1/20 | 0.31 |
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.31 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2103045 | 0.83 | TSHR (0.31) | ALDH1A1TSHRTP53 | |
| SCHEMBL2104633 | 0.79 | ESR1 (0.34) | ESR1ESR2ALDH1A1TSHRKCNN4 | |
| SCHEMBL2100521 | 0.79 | ESR1 (0.34) | ESR1ESR2ALDH1A1TSHRKCNN4 | |
| SCHEMBL2100797 | 0.77 | ESR1 (0.38) | ESR1ESR2ALDH1A1TSHRKCNN4 | |
| SCHEMBL2101348 | 0.73 | TP53 (0.33) | ESR1ESR2ALDH1A1TSHRMAPT | |
| SCHEMBL765973 | 0.72 | MEN1 (0.40) | ESR1ESR2ALDH1A1TSHRKCNN4 | |
| SCHEMBL435723 | 0.72 | ESR1 (0.37) | ESR1ESR2ALDH1A1TSHRKCNN4 | |
| SCHEMBL2276954 | 0.72 | ESR1 (0.37) | ESR1ESR2ALDH1A1TSHRKCNN4 | |
| SCHEMBL2100880 | 0.72 | AOC3 (0.32) | ESR1ESR2ALDH1A1HTR2AHRH1 | |
| SCHEMBL2102482 | 0.72 | TSHR (0.32) | ESR1ESR2TSHRLMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 47 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070087025-A1 | Reiteratively layered medical devices and method of preparing same | FITZHUGH ANTHONY | 2007-04-19 | — | — | US | claimed |
| US-20070014828-A1 | Cross-linked nitric oxide-releasing polyamine coated substrates, compositions comprising same and method of making same | GOVERNMENT OF THE USA, REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2007-01-18 | — | — | US | claimed |
| EP-1545798-A4 | CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME | US GOV HEALTH & HUMAN SERV (US) | 2006-06-14 | — | — | EP | claimed |
| EP-1545798-A1 | CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2005-06-29 | — | — | EP | claimed |
| EP-1436018-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2004-07-14 | — | — | EP | claimed |
| WO-2004012874-A1 | CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2004-02-12 | — | — | WO | claimed |
| WO-2003026717-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-04-03 | — | — | WO | claimed |
| EP-2145929-B1 | Method for manufacturing redispersible, surface-modified silicon dioxide particles | EVONIK OPERATIONS GMBH (DE) | 2020-06-24 | — | — | EP | disclosed |
| EP-2145928-B1 | Dispersion made of hydrophobic silicon dioxide particles and granulate made from same | EVONIK DEGUSSA GMBH (DE) | 2017-09-13 | — | — | EP | disclosed |
| EP-1238989-B1 | Olefin polymerization catalyst and process for producing olefin polymer with the catalyst | MITSUI CHEMICALS INC (JP) | 2015-10-07 | — | — | EP | disclosed |
| US-8404584-B2 | Method of manufacturing semiconductor device | FUJITSU LIMITED (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8399093-B2 | Process for preparing redispersible surface-modified silicon dioxide particles | EVONIK DEGUSSA GMBH (DE) | 2013-03-19 | — | — | US | disclosed |
| US-8164166-B2 | Interfacial roughness reducing film, wiring layer, semiconductor device, and method of manufacturing semiconductor device | FUJITSU LIMITED (JP) | 2012-04-24 | — | — | US | disclosed |
| EP-1436018-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2004-07-14 | — | — | EP | disclosed |
| WO-2004012874-A1 | CROSS-LINKED NITRIC OXIDE-RELEASING POLYAMINE COATED SUBSTRATES, COMPOSITIONS COMPRISING SAME AND METHOD OF MAKING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPT. OF HEALTH AND HUMAN SERVICES (US) | 2004-02-12 | — | — | WO | disclosed |
| US-20030219597-A1 | Silica-based materials and methods | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2003-11-27 | — | — | US | disclosed |
| WO-2003078159-A1 | SILICA-BASED MATERIALS AND METHODS | REGENTS OF THE UNIVERSITY OF MINNESOTA (US) | 2003-09-25 | — | — | WO | disclosed |
| WO-2003026717-A1 | NITRIC OXIDE-RELEASING COATED MEDICAL DEVICES AND METHOD OF PREPARING SAME | THE GOVERNMENT OF THE UNITED STATES OF AMERICA, REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) | 2003-04-03 | — | — | WO | disclosed |
| US-20020169072-A1 | Olefin polymerization catalyst and process for produing Olefin polymer with the catalyst | MITSUI CHEMICALS, INC. (JP) | 2002-11-14 | — | — | US | disclosed |
| EP-1238989-A2 | Olefin polymerization catalyst and process for producing olefin polymer with the catalyst | Mitsui Chemicals, Inc. (JP) | 2002-09-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070087025-A1 | Reiteratively layered medical devices and method of preparing same | NOS2, NOS1, NOS3 | ESR1 1016/4885ESR2 1178/4885ALDH1A1 2127/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.